265 related articles for article (PubMed ID: 21514344)
1. Worldwide sequence conservation of transmission-blocking vaccine candidate Pvs230 in Plasmodium vivax.
Doi M; Tanabe K; Tachibana S; Hamai M; Tachibana M; Mita T; Yagi M; Zeyrek FY; Ferreira MU; Ohmae H; Kaneko A; Randrianarivelojosia M; Sattabongkot J; Cao YM; Horii T; Torii M; Tsuboi T
Vaccine; 2011 Jun; 29(26):4308-15. PubMed ID: 21514344
[TBL] [Abstract][Full Text] [Related]
2. Plasmodium vivax gametocyte protein Pvs230 is a transmission-blocking vaccine candidate.
Tachibana M; Sato C; Otsuki H; Sattabongkot J; Kaneko O; Torii M; Tsuboi T
Vaccine; 2012 Feb; 30(10):1807-12. PubMed ID: 22245309
[TBL] [Abstract][Full Text] [Related]
3. Genetic diversity in the transmission-blocking vaccine candidate Plasmodium vivax gametocyte protein Pvs230 from the China-Myanmar border area and central Myanmar.
Zhao X; Hu Y; Zhao Y; Wang L; Wu Z; Soe MT; Kyaw MP; Cui L; Zhu X; Cao Y
Parasit Vectors; 2022 Oct; 15(1):371. PubMed ID: 36253843
[TBL] [Abstract][Full Text] [Related]
4. Plasmodium vivax gametocyte proteins, Pvs48/45 and Pvs47, induce transmission-reducing antibodies by DNA immunization.
Tachibana M; Suwanabun N; Kaneko O; Iriko H; Otsuki H; Sattabongkot J; Kaneko A; Herrera S; Torii M; Tsuboi T
Vaccine; 2015 Apr; 33(16):1901-8. PubMed ID: 25765968
[TBL] [Abstract][Full Text] [Related]
5. The evolution and diversity of a low complexity vaccine candidate, merozoite surface protein 9 (MSP-9), in Plasmodium vivax and closely related species.
Chenet SM; Pacheco MA; Bacon DJ; Collins WE; Barnwell JW; Escalante AA
Infect Genet Evol; 2013 Dec; 20():239-48. PubMed ID: 24044894
[TBL] [Abstract][Full Text] [Related]
6. Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates.
Tsuboi T; Kaslow DC; Gozar MM; Tachibana M; Cao YM; Torii M
Mol Med; 1998 Dec; 4(12):772-82. PubMed ID: 9990863
[TBL] [Abstract][Full Text] [Related]
7. A comparative study on worldwide genetic diversity and population structure analysis of Plasmodium vivax thrombospondin-related adhesive protein (PvTRAP) and its implications for the vivax vaccine design.
Nazeri S; Mehrizi AA; Djadid ND; Zakeri S
Infect Genet Evol; 2015 Dec; 36():410-423. PubMed ID: 26477931
[TBL] [Abstract][Full Text] [Related]
8. Naturally Acquired Antibody Response to Malaria Transmission Blocking Vaccine Candidate Pvs230 Domain 1.
Tentokam BCN; Amaratunga C; Alani NAH; MacDonald NJ; Narum DL; Salinas ND; Kwan JL; Suon S; Sreng S; Pereira DB; Tolia NH; Fujiwara RT; Bueno LL; Duffy PE; Coelho CH
Front Immunol; 2019; 10():2295. PubMed ID: 31636633
[No Abstract] [Full Text] [Related]
9. Global genetic diversity of the Plasmodium vivax transmission-blocking vaccine candidate Pvs48/45.
Vallejo AF; Martinez NL; Tobon A; Alger J; Lacerda MV; Kajava AV; Arévalo-Herrera M; Herrera S
Malar J; 2016 Apr; 15():202. PubMed ID: 27067024
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of two Plasmodium vivax sexual stage antigens as transmission-blocking vaccine candidates.
Zhang Y; Liu F; Zhao Y; Yang F; Bai J; Jia X; Roobsoong W; Sattabongkot J; Cui L; Cao Y; Luo E; Wang M
Parasit Vectors; 2021 Aug; 14(1):407. PubMed ID: 34399829
[TBL] [Abstract][Full Text] [Related]
11. Global distribution of single amino acid polymorphisms in
Mittal P; Mishra S; Kar S; Pande V; Sinha A; Sharma A
Open Biol; 2020 Sep; 10(9):200180. PubMed ID: 32993415
[No Abstract] [Full Text] [Related]
12. Limited genetic diversity in the global Plasmodium vivax Cell traversal protein of Ookinetes and Sporozoites (CelTOS) sequences; implications for PvCelTOS-based vaccine development.
Mehrizi AA; Torabi F; Zakeri S; Djadid ND
Infect Genet Evol; 2017 Sep; 53():239-247. PubMed ID: 28600217
[TBL] [Abstract][Full Text] [Related]
13. Limited sequence polymorphisms of four transmission-blocking vaccine candidate antigens in Plasmodium vivax Korean isolates.
Kang JM; Ju HL; Moon SU; Cho PY; Bahk YY; Sohn WM; Park YK; Cha SH; Kim TS; Na BK
Malar J; 2013 Apr; 12():144. PubMed ID: 23631662
[TBL] [Abstract][Full Text] [Related]
14. Finding the sweet spots of inhibition: understanding the targets of a functional antibody against Plasmodium vivax Duffy binding protein.
Ntumngia FB; King CL; Adams JH
Int J Parasitol; 2012 Nov; 42(12):1055-62. PubMed ID: 23068913
[TBL] [Abstract][Full Text] [Related]
15. Genetic diversity and natural selection of transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 in Plasmodium vivax Myanmar isolates.
Lê HG; Kang JM; Jun H; Lee J; Moe M; Thái TL; Lin K; Myint MK; Yoo WG; Sohn WM; Kim TS; Na BK
Acta Trop; 2019 Oct; 198():105104. PubMed ID: 31336059
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the genetic diversity of domain II of Plasmodium vivax Apical Membrane Antigen 1 (PvAMA-1) and the ensuing strain-specific immune responses in patients from Sri Lanka.
Dias S; Somarathna M; Manamperi A; Escalante AA; Gunasekera AM; Udagama PV
Vaccine; 2011 Oct; 29(43):7491-504. PubMed ID: 21784116
[TBL] [Abstract][Full Text] [Related]
17. Plasmodium vivax: genetic diversity of the apical membrane antigen-1 (AMA-1) in isolates from India.
Rajesh V; Elamaran M; Vidya S; Gowrishankar M; Kochar D; Das A
Exp Parasitol; 2007 Jul; 116(3):252-6. PubMed ID: 17336299
[TBL] [Abstract][Full Text] [Related]
18. Genetic diversity of transmission blocking vaccine candidate (Pvs25 and Pvs28) antigen in Plasmodium vivax clinical isolates from Iran.
Zakeri S; Razavi S; Djadid ND
Acta Trop; 2009 Mar; 109(3):176-80. PubMed ID: 18950597
[TBL] [Abstract][Full Text] [Related]
19. Nucleotide sequence polymorphism at the apical membrane antigen-1 locus reveals population history of Plasmodium vivax in Thailand.
Putaporntip C; Jongwutiwes S; Grynberg P; Cui L; Hughes AL
Infect Genet Evol; 2009 Dec; 9(6):1295-300. PubMed ID: 19643205
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for neutralization of Plasmodium vivax by naturally acquired human antibodies that target DBP.
Urusova D; Carias L; Huang Y; Nicolete VC; Popovici J; Roesch C; Salinas ND; Dechavanne S; Witkowski B; Ferreira MU; Adams JH; Gross ML; King CL; Tolia NH
Nat Microbiol; 2019 Sep; 4(9):1486-1496. PubMed ID: 31133752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
